Readmissions After Continuous Flow Left Ventricular Assist Device Implantation: Differences Observed Between Two...

Area of Science:

• Cardiology
• Medical Devices
• Clinical Research

Background:

• Readmissions are common after continuous flow left ventricular assist device (CF-LVAD) implantation.
• Understanding readmission patterns is crucial for improving patient outcomes.

Purpose of the Study:

• To compare the frequency and causes of readmissions between HeartMate-II (HM-II) and HeartWare (HW) CF-LVADs within six months post-implantation.
• To identify specific clinical profiles associated with readmissions in CF-LVAD patients.

Main Methods:

• Retrospective assessment of 81 patients receiving HM-II (n=35) or HW (n=46) CF-LVADs as bridge to transplant.
• Readmissions categorized into cardiac, infection, gastrointestinal bleeding, stroke, pump thrombosis, and miscellaneous profiles.
• Analysis of readmission rates and etiologies at six months post-implant.

Main Results:

• Overall readmission rate was higher for HM-II recipients (2.3) versus HW recipients (1.4) at six months (p=0.024).
• Multiple readmissions (≥2) were more frequent in HM-II recipients (66%) compared to HW recipients (44%) (p=0.047).
• Arrhythmia and infection were significantly more common reasons for readmission in HM-II recipients.

Conclusions:

• Significant differences exist in readmission frequency and patterns between HM-II and HW CF-LVADs.
• HM-II recipients experienced higher rates of overall and multiple readmissions, particularly due to arrhythmias and infections.
• Device choice may influence early post-implantation readmission profiles in CF-LVAD patients.